Here we characterize alterations in the biomechanical responses of bones from PPARβ−/− mice and identify new molecular targets, namely PPARγ and myostatin, that may contribute to the impairment of the muscle and bone functions in diabetes. The gene discussed is MSTN; the disease is diabetes mellitus.